Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_assertion type Assertion NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_head.
- NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_assertion description "[In this study, we show that imatinib triggers SPARC accumulation in a variety of tyrosine kinase inhibitor (TKI)-resistant CML cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_provenance.
- NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_assertion evidence source_evidence_literature NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_provenance.
- NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_assertion SIO_000772 21098700 NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_provenance.
- NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_assertion wasDerivedFrom befree-2016 NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_provenance.
- NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_assertion wasGeneratedBy ECO_0000203 NP853953.RAfqXpCU5iQKj0yWKRmp479nmg47-q8zzjm8VkFKq-hOQ130_provenance.